PDIA3 and neoplasm: The heterogeneous results indicated that the PDIA3 was a hazardous prognostic marker in eighteen independent tumor cohorts and a favorable prognostic marker in fifteen independent tumor cohorts including melanoma in regard to OS (Figure 2G).